Advertisement
Screener

STERIS plc (STE) Goodwill, Foreign Currency Translation Gain (Loss)

2.7 / 5 stars · 49/91 Roast Me

STERIS plc Goodwill, Foreign Currency Translation Gain (Loss)

STERIS plc (STE) reported Goodwill, Foreign Currency Translation Gain (Loss) of $90.40 million for the 12-month period ending 2026-03-31, per its 10-K filed 2026-05-29.

Financial Statements › Income Statement › Other Income

us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-05-29

  • STERIS plc goodwill, foreign currency translation gain (loss) for the quarter ending 2024-03-31 was -$43.89M, a 196.87% decline year-over-year.
  • STERIS plc goodwill, foreign currency translation gain (loss) for the quarter ending 2023-12-31 was $74.96M, a 45.84% decline year-over-year.
  • STERIS plc goodwill, foreign currency translation gain (loss) for the quarter ending 2023-03-31 was $45.31M.
  • STERIS plc goodwill, foreign currency translation gain (loss) for the quarter ending 2022-12-31 was $138.40M.
  • STERIS plc goodwill, foreign currency translation gain (loss) for fiscal 2026 was $90.40M, a 242.42% increase from fiscal 2025.
  • STERIS plc goodwill, foreign currency translation gain (loss) for fiscal 2025 was $26.40M.
  • STERIS plc goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$6.02M.
  • STERIS plc goodwill, foreign currency translation gain (loss) for fiscal 2023 was -$45.95M.
Period endGoodwill, Foreign Currency Translation Gain (Loss) 3 monthGoodwill, Foreign Currency Translation Gain (Loss) 6 monthGoodwill, Foreign Currency Translation Gain (Loss) 9 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 monthGoodwill, Foreign Currency Translation Gain (Loss) 12 month as first filed
2026-03-31$90.40M
10-K · filed 2026-05-29
2025-03-31$26.40M
10-K · filed 2026-05-29
$26.43M
10-K · filed 2025-05-29
2024-03-31-$43.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-29
$31.07M
derived: sum of 2 quarters · filed 2025-05-29
-$6.02M
10-K · filed 2025-05-29
2023-12-31$74.96M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08
$37.87M
10-Q · filed 2024-02-08
2023-09-30-$37.09M
10-Q · filed 2023-11-07
2023-03-31$45.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-29
$183.71M
derived: sum of 2 quarters · filed 2024-05-29
-$45.95M
10-K · filed 2024-05-29
-$61.31M
10-K · filed 2023-05-26
2022-12-31$138.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08
-$91.25M
10-Q · filed 2024-02-08
2022-09-30-$229.65M
10-Q · filed 2023-11-07
2022-03-31-$121.27M
10-K · filed 2023-05-26
2021-03-31$99.48M
10-K · filed 2022-05-31
2020-03-31-$41.17M
10-K · filed 2021-05-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
ZIMMER BIOMET HOLDINGS, INC. (ZBH)United States$17.103B20.66
ALIGN TECHNOLOGY INC (ALGN)United States$10.346B29.06
MSA Safety Inc (MSA)United States$7.023B21.47
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Enovis CORP (ENOV)United States$1.053B-1.18
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B